Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth - sprookjes - yvandenbroek - TriplyDB

Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth

Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth

http://www.wikidata.org/entity/Q24521364

about

Insights into the molecular evolution of the PDZ/LIM family and identification of a novel conserved protein motif The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth The Ubiquitination of NF-κB Subunits in the Control of Transcription IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy Resistance PDlim2 Selectively Interacts with the PDZ Binding Motif of Highly Pathogenic Avian H5N1 Influenza A Virus NS1 A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm.Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level Characterization of the interaction between Actinin-Associated LIM Protein (ALP) and the rod domain of alpha-actinin.Pdlim7 is required for maintenance of the mesenchymal/epidermal Fgf signaling feedback loop during zebrafish pectoral fin development.Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.ALP/Enigma PDZ-LIM domain proteins in the heart.Zasp regulates integrin activation.Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages.Systematic analysis of bacterial effector-postsynaptic density 95/disc large/zonula occludens-1 (PDZ) domain interactions demonstrates Shigella OspE protein promotes protein kinase C activation via PDLIM proteins The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system Exome sequencing reveals a novel TTC19 mutation in an autosomal recessive spinocerebellar ataxia patient NF-κB and cancer: a paradigm of Yin-Yang.Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components.Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.Gene expression patterns in visual cortex during the critical period: synaptic stabilization and reversal by visual deprivation.DNA methylation patterns in lung carcinomas.Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax.PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.Nucleocytoplasmic functions of the PDZ-LIM protein family: new insights into organ development.Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.Regulation of epithelial proliferation by tight junction proteins.PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling.MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways.

P2860

Q21144465-EC2B71DB-B956-4F30-BE6C-64293ACAD0AE Q24314865-AE61EBD7-7959-40A7-9E97-83A2FB60900E Q26748938-B8F05601-5EFA-436E-96BA-3FFE647574E1 Q26802042-0FEFAC8A-11A5-4DE9-A21A-1FF1231985E4 Q27668086-68EC6EAD-C36B-4F8B-B100-57E8729B2014 Q28302336-353A3121-10D7-4540-A974-FAC5A8862DC0 Q31032656-7D8AE670-6550-454A-90B5-869A0C342F8A Q33347932-0DE80C7E-DA26-426E-A96C-6220AC6F9034 Q33423240-EF379422-0C17-49FA-AFA9-41B6A2EC330A Q33719886-DCA96430-3FF5-4645-B9BB-18EA4E6F1648 Q33782392-2E0EEBD8-7055-4CA9-BCC6-F1A10EF23731 Q33809716-97D697DA-F20C-4471-A0DD-8CA588C52B6D Q33999361-16C73B83-89D9-40ED-85A3-4F4D9E1CD919 Q34300649-DE5A8595-3DF4-45E8-BFA7-E2EC5B52C0CE Q34333812-31EEBBBC-42F2-4D04-9F38-09422A11D44F Q34397010-B6B2AA05-BCD8-4682-A416-684209B870BE Q34596754-B6C9086C-02A6-47A8-B095-47EF8A75F6F6 Q35084390-E35D11E6-0EE0-4287-8297-215B3CC077A1 Q35232248-0BE36355-0BEB-4DCA-A61D-00C61613F4E7 Q35813817-EBF25252-B121-450D-AF17-D867571F2E12 Q35859571-FB264AEF-6A83-4591-9C77-5B23EFA77869 Q36012548-338AD02E-469A-4517-B02E-9CE779242AA5 Q36740613-DCFA9BE2-5608-44BB-B3AF-73B6DFE7B82F Q36756849-C0D980C5-F779-4C61-B909-A2FAA81840DD Q37188534-A549630B-622B-4110-B671-1FF19B2CF1B2 Q37350642-D42F2326-1DBD-4A4F-9E99-CA23D3C64B94 Q37416507-0F8CCA23-F5F4-40B1-8FF5-77987628CD11 Q37679075-6B38C89A-1208-4010-AB67-A4CE150CFAB1 Q37683382-90B43A46-C84E-4768-82BB-3F9A2D0AC705 Q38021500-ABA4D59D-6E2E-4711-9EA2-028A96459DC3 Q38825075-E82E0029-7098-4273-A956-62043F44DA14 Q38991274-7F005628-164C-4ABC-9E8D-8425D52150A8 Q39781832-7CD6F718-F409-4DCE-AC5C-FD5485879DDB Q39909557-2F076C7D-2B18-4286-8C71-ADB4A053C0FE Q40198127-66DFD5ED-AB8C-4DEE-946E-EBCDF86F4960 Q41273648-3C5DAB22-1F73-4253-9880-6E20E71E2FB7 Q41566034-02D40637-229F-454E-9E50-20FFB65D6997 Q41595626-586ADE18-F736-4D71-87C7-6CA43A275F30 Q42292787-EDF616D8-E14C-4EFF-BBE5-F43C5495228E Q43121706-86AAAC34-7DF9-418C-9D71-AF157D3EB0A8

P2860

Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth

http://www.wikidata.org/entity/Q24521364

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Mystique is a new insulin-like ...... s Anchorage-independent growth

@ast

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en-gb

Mystique is a new insulin-like ...... s Anchorage-independent growth

@nl

type

label

Mystique is a new insulin-like ...... s Anchorage-independent growth

@ast

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en-gb

Mystique is a new insulin-like ...... s Anchorage-independent growth

@nl

prefLabel

Mystique is a new insulin-like ...... s Anchorage-independent growth

@ast

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en-gb

Mystique is a new insulin-like ...... s Anchorage-independent growth

@nl

P1433

Q24521364-BF6BC60A-B936-44A2-88F2-F11A899A595C

P1476

Q24521364-3BEA1AA1-5CBC-4704-BCB6-3794127B052D

P2093

Q24521364-25320AFB-78EA-408C-8F07-39CCD64D2BC9

Q24521364-77F1CD72-A83D-429E-852C-4EF5CB6C4665

Q24521364-8C158688-9ABC-499A-ACDC-9E78EAD37F73

Q24521364-FDCD5E85-7810-4D6E-AE3F-8978BE24E40E

P2860

Q24521364-03F558B3-198F-4641-967D-F0FB340D5FA7

Q24521364-060A2BE6-CC75-490C-B22F-52C9307A07C4

Q24521364-0860E4F9-849D-4444-8D56-455535D41427

Q24521364-08D01147-16F6-4AA6-B064-5E8451F200CD

Q24521364-0FB25FD3-3E4B-453D-BB39-E47FA1D7599B

Q24521364-13A4580B-AD1C-4A9D-9EF0-8541A8AC656E

Q24521364-253ADE07-4D60-4FBA-BCD4-FF3F01347F52

Q24521364-25730ED3-2708-4B2F-AED2-ED0894B17EF7

Q24521364-27E4D13B-6A48-42F3-9256-5E3A01F4422C

Q24521364-28632FFC-90DE-430B-AF51-29466D00946F

P304

Q24521364-79D659C8-BE90-4F2D-A7D9-A195CF3ACCD6

P31

Q24521364-11265975-AC2F-4644-B7D8-AAFD8914A49B

P3181

Q24521364-F2246ED4-82CC-4FB7-A4E8-C5A0B7F50864

P356

Q24521364-6592010F-426E-41D9-AE96-A5C4FBF76DC5

P407

Q24521364-327BA431-6410-4307-966D-CC0EAC54A552

P433

Q24521364-915E4479-03DE-4A71-9734-3A035803C3DC

P478

Q24521364-01D36028-79D4-4524-9B56-B292D8D29476

P50

Q24521364-45925EBA-F41A-47C4-9D50-6151968E297B

Q24521364-CCA4A7DE-08B7-4176-9406-CFE20113B3EA

P577

Q24521364-FFD3B583-279D-43AA-A084-BF0E4A44DFA7

P5875

Q24521364-3CC7F5A1-A2B5-4BF1-8ED3-17C81BB45C81

P698

Q24521364-E76A330F-DB0C-4B68-94CF-8F583276833B

P921

Q24521364-584E3E4C-2588-4AED-9F60-2587993277B8

Q24521364-EC1CBDB8-4004-4013-967D-98D3F9720604

P932

Q24521364-1F848455-355A-4AEE-B19F-E216993C98E1

P3181

P356

MBC.E04-12-1052

P1433

Molecular Biology of the Cell

P1476

Mystique is a new insulin-like ...... s Anchorage-independent growth

@en

P2093

Merei Huigsloot

http://www.w3.org/2001/XMLSchema#string

Nancy L Kedersha

http://www.w3.org/2001/XMLSchema#string

Nollaig C Healy

http://www.w3.org/2001/XMLSchema#string

Patrick A Kiely

http://www.w3.org/2001/XMLSchema#string

P2860

ZASP: a new Z-band alternatively spliced PDZ-motif protein

The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein

Cloning of a rat cDNA encoding a novel LIM domain protein with high homology to rat RIL

Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs

LIM domain recognition of a tyrosine-containing tight turn

Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.

Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility

Differential regulation of cell motility and invasion by FAK

Protein-protein interaction of zinc finger LIM domains with protein kinase C

The LIM domain: regulation by association

P304

1811-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1678031

http://www.w3.org/2001/XMLSchema#string

P356

10.1091/MBC.E04-12-1052

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Rosemary O'Connor

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8071098

http://www.w3.org/2001/XMLSchema#string

P698

15659642

http://www.w3.org/2001/XMLSchema#string

P921

P932

1073663

http://www.w3.org/2001/XMLSchema#string